Tempest Therapeutics Inc (TPST) — Cash Flow Reinvestment Rate
Latest as of June 2021:
1.10x
Tempest Therapeutics Inc (TPST) has a Cash Flow Reinvestment Rate of 1.10x as of June 2021, reinvesting $140.00K (capex $70.00K plus investments $-70.00K) from operating cash flow of $127.00K. Explore cash flow conversion of Tempest Therapeutics Inc to assess how effectively this company generates cash.
Reinvestment Rate
1.10x
(Capex + Investments) / Operating CF
Total Reinvested
$140.00K
Capex + Investments
Operating Cash Flow
$127.00K
USD
Capital Expenditures
$70.00K
USD
Annual Cash Flow Reinvestment Rate for Tempest Therapeutics Inc (None–None)
Year-by-year capital reinvestment analysis for Tempest Therapeutics Inc. For live market cap and broader valuation context, see market cap of Tempest Therapeutics Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow